Valuation: Proto Script Pharmaceutical Corp.

Market Cap 1.97M 1.7M 1.59M 1.45M 2.73M 188M 2.76M 18.66M 7.31M 94.16M 7.38M 7.22M 313M P/E 2015 *
-
P/E 2016 -41.4x
Enterprise Value 2.01M 1.74M 1.63M 1.49M 2.79M 193M 2.83M 19.12M 7.49M 96.45M 7.56M 7.4M 321M EV / Sales 2015 *
-
EV / Sales 2016 394x
Free-Float
89.82%
Yield 2015 *
-
Yield 2016 -
1 week-50.00%
Current month-50.00%
1 month-50.00%
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0.02
10 years 0
Extreme 1.0E-6
2.2
Manager TitleAgeSince
Chief Executive Officer 58 28/06/2016
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-50.00%-.--%-98.00% 11.38K
+0.67%-2.41%-8.65%+63.51% 79.16B
+0.71%-2.51%-2.92%+7.99% 16.81B
-0.14%-1.99%+3.34%+13.18% 14.21B
-0.21%0.00%+25.48%+44.02% 12.18B
-1.64%-5.67%+19.11%+99.01% 8.12B
-0.41%+2.32%+52.75%+145.56% 7.11B
+2.33%-1.26%-22.81%-6.39% 5.66B
0.00%-2.90%+18.79%-0.52% 5.38B
+1.88%-1.45%-18.38%+25.72% 5.24B
Average +0.24%-0.89%+6.67%+29.41% 15.39B
Weighted average by Cap. +0.40%-1.47%+0.20%+50.82%

Financials

2015 2016
Net sales 881K 761K 714K 650K 1.22M 84.28M 1.24M 8.37M 3.28M 42.22M 3.31M 3.24M 140M 789K 681K 639K 582K 1.09M 75.44M 1.11M 7.49M 2.94M 37.79M 2.96M 2.9M 126M
Net income -145K -125K -118K -107K -201K -13.89M -204K -1.38M -540K -6.96M -545K -534K -23.14M -7.18M -6.2M -5.82M -5.3M -9.96M -687M -10.1M -68.2M -26.72M -344M -26.97M -26.38M -1.14B
Net Debt 27.07K 23.37K 21.92K 19.97K 37.55K 2.59M 38.07K 257K 101K 1.3M 102K 99.43K 4.31M 47.78K 41.25K 38.7K 35.25K 66.28K 4.57M 67.2K 454K 178K 2.29M 179K 176K 7.61M
Logo Proto Script Pharmaceutical Corp.
Proto-Script Pharmaceuticals, Corp., formerly Yanex Group, Inc. is a development-stage company. The Company is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. The Company has various contracts with state and governmental insurance providers, among others. These contracts provide the Company the right to sell and repair DME. The Company's health care insurance contracts allow it the ability to service patients nationally. The Company intends to expand its market through additional contracts and open several repair facilities throughout the continental United States. The Company currently has repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California. As of June 30, 2016, the Company had not generated any revenues.
Employees
13
  1. Stock Market
  2. Stocks
  3. PSCR Stock